Share
Export Citation
APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journal›Article›peer-review
The value of tumor-infiltrating lymphocytes and CD8 expression as a predictor of response to anthracycline-based neoadjuvant chemotherapy in invasive breast carcinoma of no special type
Miskad U.A.
Breast Disease
Q3Published: 2021Citations: 5
Abstract
This study results suggest that TILs level and CD8 expression may be added as predictive factors to the response of anthracycline-based neoadjuvant chemotherapy, and oncologists may take benefit in breast cancer patient's management.
Access to Document
10.3233/BD-219002Other files and links
Fingerprint
MedicineSciences
Tumor-infiltrating lymphocytesSciences
AnthracyclineSciences
Breast cancerSciences
ChemotherapySciences
Neoadjuvant therapySciences
OncologySciences
Breast carcinomaSciences
Internal medicineSciences
H&E stainSciences
BiopsySciences
CD8Sciences
PathologySciences
ImmunohistochemistrySciences
CancerSciences
Immune systemSciences
ImmunotherapySciences
ImmunologySciences